NCT06319313 2024-03-20Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung CancerShanghai JMT-Bio Inc.Phase 2/3 Not yet recruiting534 enrolled
NCT01721759 2022-06-28Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic RegimensBristol-Myers SquibbPhase 2 Completed117 enrolled 17 charts